|
Feb 2 2026
Feedback.
Google Search: Keyword Search: |
[ Receptor Considerations | Ligand Considerations | Chirality Considerations | Protonation Considerations | Internal Hydrogen Bonds | Pyramidal Sampling | Membrane Exposed Docking | Waters | Scoring | Ligand Strain ]
This section is concerned with predictions of interactions of drugs or small biological substrates (less than about 600-700 Da) to pockets in protein molecules, DNA or RNA. For accurate ligand docking, the goal is to have an adequate three-dimensional model of the receptor pocket you are planning to dock ligands to. If this is the case then ICM docking has been shown to be very accurate in a number of independent assessments. However, there are a number of pitfalls which need to be overcome to achieve accurate ligand docking. The pitfalls are that your model is not accurate overall, does not reflect the induced fit, or alternative conformations of the receptor binding pocket are missed. MolSoft has a number of in built tools to overcome some of these challenges Some key points about ICM Ligand Docking:
Please click here to read more about ICM Docking.
If you have only a single PDB entry for your receptor, convert the protein to an ICM object, delete water molecules and irrelevant chains. However, if you have a choice between several templates, take the following into account:
Usually a good place to start is to try to dock the known ligand(s) to the receptor model. You may also want to dock a library of compounds in order to identify lead candidates. In this case the main pitfalls are that the library is too restricted, molecules are not chemically feasible or not drug-like. For peptide docking please use the peptide docking protocol. There is no need to convert the ligands to 3D, this is done "on-the-fly" during the docking process.
To sample linear chiral centers during docking you can check the option "Sample Racemic Centers" in Docking/Preferences/General. To sample chiral centers in rings it is best to generate all 2D enantiomers using Chemistry/Generate Stereoisomers. For most linear cases 'sample racemic centers' is acceptable. For most rigorous treatment one should pre-generate all stereoisomers (Chemistry/Generate Stereoisomers). If you do not select anything you get one (essentially arbitrary) stereoisomer docked.
The protonation state can be set in the Docking/Preferences/General dialog box. Choose the drop down option in the field labeled Charge Groups. To use MolSoft's pKa model choose the option auto, which uses built-in prediction of Ka/Kb to charge and protonate/deprotonate appropriate groups. If you do not want to use the pKa model then charges of some ionizable basic groups can be set, it currently accepts the following values: NH2, NH, NT for primary secondary and tertiary aliphatic amines. There are also options for imidazole and amidine.The none option still charges acids unless neutralAcids flag is set to no in the docking table file .dtb or .tab. To determine protonation at a range of pH values you can use the options in Chemistry/Set Formal Charges/ and choose the option Auto using Pka Model.
Internal hydrogen bonds are taken into account during docking by default. You can check in the docking_project_name.dtb table file to make sure that l_internalHB field is 'yes'.
If the parameter
( If you are docking to a membrane-exposed site, set the
Note: This flag modifies several terms of the VLS score to account for a low-dielectric environment.
|